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Introduction {#jah31353-sec-0004}
============

Cardiovascular diseases (CVDs) are the leading causes of disability and death in the world and in 2010 were considered the main risk factor for the overall global burden of disease.[1](#jah31353-bib-0001){ref-type="ref"}, [2](#jah31353-bib-0002){ref-type="ref"}According to the World Health Organization,[3](#jah31353-bib-0003){ref-type="ref"} ≈17.3 million people worldwide died from CVD in 2008, and 80% of CVD‐related deaths were recorded in low‐ and middle‐income countries. Among CVDs, heart disorder has reportedly claimed 7.3 million lives, whereas stroke has caused 6.2 million deaths. Low‐cost, easily accessible, and symptom‐free programs are needed to treat and prevent CVD.

Physical inactivity is estimated to be the fourth main risk factor for global mortality.[4](#jah31353-bib-0004){ref-type="ref"}, [5](#jah31353-bib-0005){ref-type="ref"} Regular exercise is shown to have significant benefits for the maintenance of blood pressure and blood cholesterol.[6](#jah31353-bib-0006){ref-type="ref"}, [7](#jah31353-bib-0007){ref-type="ref"}, [8](#jah31353-bib-0008){ref-type="ref"} The practice and increasing global popularity of traditional Chinese exercises (TCEs), such as tai chi, qigong, and baduanjin, for \>2000 years has substantially benefited human health.[9](#jah31353-bib-0009){ref-type="ref"}, [10](#jah31353-bib-0010){ref-type="ref"}, [11](#jah31353-bib-0011){ref-type="ref"}, [12](#jah31353-bib-0012){ref-type="ref"}, [13](#jah31353-bib-0013){ref-type="ref"} TCE is a low‐risk, promising intervention that can help improve physiological outcomes, biochemical outcomes, physical function, quality of life, and depression among patients with CVD.[14](#jah31353-bib-0014){ref-type="ref"}, [15](#jah31353-bib-0015){ref-type="ref"}, [16](#jah31353-bib-0016){ref-type="ref"}

Although TCEs have been widely performed for the prevention and treatment of CVD,[17](#jah31353-bib-0017){ref-type="ref"}, [18](#jah31353-bib-0018){ref-type="ref"} no consensus has been reached about the benefits of these exercises for the maintenance of physiological outcomes, biochemical outcomes, physical function, and quality of life or for the prevention of depression among CVD patients. We are also unaware of any systematic reviews that have assessed the effect of TCEs on physiological outcomes, blood cholesterol, quality of life, and depression among patients with CVD.

The effect of TCEs in CVD patients must be determined based on scientific evidence to conserve time and resources. The objective of this systematic review was to determine the effects of TCEs on physiological outcomes, biochemical outcomes, physical function, quality of life, and depression among CVD patients.

Methods {#jah31353-sec-0005}
=======

The protocol for our study is registered in the international prospective register of systematic reviews (PROSPERO registration number CRD42013006474).

Search Strategy {#jah31353-sec-0006}
---------------

Relevant studies published between January 1957 and January 2015 were obtained from the following electronic data sources: PubMed, Embase, Web of Science, the Cochrane Library, Cumulative Index to Nursing and Allied Health Literature (CINAHL), and the China National Knowledge Infrastructure. No language restrictions were imposed, and the search was limited to randomized controlled trials (RCTs). The full electronic search strategies for all databases are provided in Data S1.

Inclusion Criteria {#jah31353-sec-0007}
------------------

First, the only studies covered were published RCTs. Second, we included articles that discussed patients with CVD including ischemic heart disease or coronary artery disease (eg, heart attack), cerebrovascular disease (eg, stroke), diseases of the aorta and arteries (eg, hypertension), and peripheral vascular disease. Third, we considered only articles that compared an intervention group, that is, a group performing TCEs (eg, tai chi, qigong, baduanjin) with a control group that performed other exercises (eg, strength exercises), that received usual care, or that did not undergo any intervention. Fourth, outcome measures included physiological outcomes (eg, blood pressure, heart rate, peak oxygen uptake), biochemical outcomes (eg, cholesterol and triglyceride \[TG\]), physical function (eg, 6‐minute walk test, timed up and go test), quality of life (eg, Minnesota Living With Heart Failure Questionnaire \[MLHFQ\], General Health Questionnaire \[GHQ\], and 36‐Item Short Form \[SF‐36\]), and depression (eg, Hamilton Depression Rating Scale \[HAMD\], Profile of Mood States \[POMS\] depression scale).

Selection of Studies {#jah31353-sec-0008}
--------------------

Two authors independently used the same selection criteria to screen the titles, abstracts, and full contents of the relevant articles. A study was removed from the selection if the inclusion criteria were not fulfilled. Any disagreements were resolved by discussion. A third author was consulted if a disagreement persisted.

Data Extraction and Management {#jah31353-sec-0009}
------------------------------

The following data were extracted: study characteristics (eg, author and year), participant characteristics (eg, age and number of participants), description of interventions, duration of trial period, types of assessed outcomes, and time points. The 2 authors who selected the studies also extracted the data from the included articles. Any disagreement was resolved by discussion, and a third author was consulted if a disagreement persisted.

Quality Assessment {#jah31353-sec-0010}
------------------

As recommended,[19](#jah31353-bib-0019){ref-type="ref"} we used the Cochrane Collaboration tool for assessing the risk of bias of the included trials. The following information was evaluated: random sequence generation, allocation concealment, blinding of participants and personnel, blinding of outcome assessments, incomplete outcome data, selective reporting, and other sources of bias.

The trials were graded as unclear, high, or low risk of bias. The methodological quality of each study was independently assessed by 2 review authors. A third author was consulted if any disagreement occurred.

Statistical Analysis {#jah31353-sec-0011}
--------------------

The Review Manager software (RevMan 5.2; Cochrane Collaboration) was used to conduct the meta‐analysis. We used the chi‐square test and the I^2^ statistic to evaluate heterogeneity among the studies. The outcome measures from the individual studies were combined by meta‐analysis using a random‐effects model. Given that all variables in the included studies were continuous data, we used the standardized mean difference (SMD) or mean difference (MD) and 95% CI to analyze the studies. The MD was used as a summary statistic in meta‐analysis when all studies reported the same outcome using the same scale. The SMD was used as a summary statistic in meta‐analysis when all studies assessed the same outcome using different scales (ie, the outcome was measured using different units). We considered *P*\<0.05 to be statistically significant. Funnel plot asymmetry was used to assess possible publication bias by the Egger\'s regression test. Sensitivity analysis was conducted by removing each study individually to evaluate the quality and consistency of the results.

If the continuous data were reported as median and interquartile range, the median would be assumed to be equivalent to the mean, and the relationship of interquartile range and the standard deviation would be roughly computed as SD=IQR/1.35.[20](#jah31353-bib-0020){ref-type="ref"} The standard deviation could be obtained from the standard error of a mean by multiplying by the square root of the sample size: SD=SE×$\sqrt{N}$.[20](#jah31353-bib-0020){ref-type="ref"} In specific cases, we also estimated the means and standard deviations for the data and reported them graphically rather than in a table. The authors of the selected studies were contacted if the standard deviations were not shown in the paper or could not be derived from their data. If the authors contacted did not reply, their articles were excluded.

Results {#jah31353-sec-0012}
=======

Search Results {#jah31353-sec-0013}
--------------

We identified 68 potentially eligible records from the 2824 records obtained from PubMed, the Cochrane Library, Embase, CINAHL, the China National Knowledge Infrastructure, and Web of Science. After reviewing the full content of the papers, 35 articles[21](#jah31353-bib-0021){ref-type="ref"}, [22](#jah31353-bib-0022){ref-type="ref"}, [23](#jah31353-bib-0023){ref-type="ref"}, [24](#jah31353-bib-0024){ref-type="ref"}, [25](#jah31353-bib-0025){ref-type="ref"}, [26](#jah31353-bib-0026){ref-type="ref"}, [27](#jah31353-bib-0027){ref-type="ref"}, [28](#jah31353-bib-0028){ref-type="ref"}, [29](#jah31353-bib-0029){ref-type="ref"}, [30](#jah31353-bib-0030){ref-type="ref"}, [31](#jah31353-bib-0031){ref-type="ref"}, [32](#jah31353-bib-0032){ref-type="ref"}, [33](#jah31353-bib-0033){ref-type="ref"}, [34](#jah31353-bib-0034){ref-type="ref"}, [35](#jah31353-bib-0035){ref-type="ref"}, [36](#jah31353-bib-0036){ref-type="ref"}, [37](#jah31353-bib-0037){ref-type="ref"}, [38](#jah31353-bib-0038){ref-type="ref"}, [39](#jah31353-bib-0039){ref-type="ref"}, [40](#jah31353-bib-0040){ref-type="ref"}, [41](#jah31353-bib-0041){ref-type="ref"}, [42](#jah31353-bib-0042){ref-type="ref"}, [43](#jah31353-bib-0043){ref-type="ref"}, [44](#jah31353-bib-0044){ref-type="ref"}, [45](#jah31353-bib-0045){ref-type="ref"}, [46](#jah31353-bib-0046){ref-type="ref"}, [47](#jah31353-bib-0047){ref-type="ref"}, [48](#jah31353-bib-0048){ref-type="ref"}, [49](#jah31353-bib-0049){ref-type="ref"}, [50](#jah31353-bib-0050){ref-type="ref"}, [51](#jah31353-bib-0051){ref-type="ref"}, [52](#jah31353-bib-0052){ref-type="ref"}, [53](#jah31353-bib-0053){ref-type="ref"}, [54](#jah31353-bib-0054){ref-type="ref"}, [55](#jah31353-bib-0055){ref-type="ref"} satisfied the inclusion criteria. The remaining 33 articles were excluded for several reasons (eg, participants did not have CVD, studies were not randomized). The process of identifying the eligible studies is outlined in Figure [1](#jah31353-fig-0001){ref-type="fig"}. Table [1](#jah31353-tbl-0001){ref-type="table-wrap"} summarizes the characteristics of each included study. The 35 articles covered 2249 patients with CVD (15 articles covered patients with heart disease, 13 articles covered those with hypertension, and 7 articles covered those with cerebrovascular disease). The countries or regions of publication were mainly the People\'s Republic of China (n=17, 48.57%), the United States (n=5, 14.28%), the United Kingdom (n=3, 8.57%), the Republic of Korea (n=3, 8.57%), Japan (n=2, 5.71%), Hong Kong (n=1, 2.85%), Italy (n=1, 2.85%), Taiwan (n=1, 2.85%), New Zealand (n=1, 2.85%), and Israel (n=1, 2.85%).

![Flow chart of the study selection procedure. CKNI indicates China National Knowledge Infrastructure.](JAH3-5-e002562-g001){#jah31353-fig-0001}

###### 

Characteristics of Included Studies

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Article, Year                                                  Country/Region     Participant Characteristics, Sample Size                                                                                                                                    Disease                                           Intervention                                             Duration of Trial Period                                     Outcomes                                                                                                                                                                                   Time Point
  -------------------------------------------------------------- ------------------ --------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------- -------------------------------------------------------- ------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ -------------------
  Barrow (2007)[21](#jah31353-bib-0021){ref-type="ref"}          UK                 65 participants (G1=32, G2=33). Mean age: G1=68.4 years, G2=67.9 years                                                                                                      Heart failure                                     G1: Tai chi exercise\                                    Twice a week for 16 weeks                                    Physiological outcomes (blood pressure), quality of life (MLHFQ), depression (SCL‐R depression index)                                                                                      16 weeks
                                                                                                                                                                                                                                                                                                                  G2: Standard medical care                                                                                                                                                                                                                                                                                        

  Blake (2009)[22](#jah31353-bib-0022){ref-type="ref"}           UK                 20 participants (G1=10, G2=10). Mean age (SD): G1=46.2 years (11.27), G2=44.5 years (10.52). Mean duration of disease (SD): G1=16.40 years (9.04), G2=14.98 years (13.62)   Brain injury                                      G1: Tai Chi and qigong exercise\                         Once a week for 8 weeks                                      QOL (GHQ)                                                                                                                                                                                  8 weeks
                                                                                                                                                                                                                                                                                                                  G2: No exercise                                                                                                                                                                                                                                                                                                  

  Cai (2010)[23](#jah31353-bib-0023){ref-type="ref"}             China              60 participants (G1=30, G2=30). Mean age (SD): G1=60.3 years (10.5), G2=61.3 years (7.4)                                                                                    Stroke                                            G1: Baduanjin and health education\                      4 to 5 times a week for 3 months                             QOL (WHOQOL‐BREF)                                                                                                                                                                          3 months
                                                                                                                                                                                                                                                                                                                  G2: Health education                                                                                                                                                                                                                                                                                             

  Caminiti (2011)[24](#jah31353-bib-0024){ref-type="ref"}        Italy              60 participants (G1=30, G2=30). Mean age (SD): G1=73.4 years (2), G2=73.8 years (6). Duration of disease: \>3 months                                                        Chronic heart failure                             G1: Tai chi exercise plus endurance training\            4 sessions a week for 8 weeks                                Physiological outcomes (blood pressure, heart rate), physical function (6MWT)                                                                                                              12 weeks
                                                                                                                                                                                                                                                                                                                  G2: Endurance training                                                                                                                                                                                                                                                                                           

  Channer (1996)[25](#jah31353-bib-0025){ref-type="ref"}         UK                 79 participants (G1=38, G2=41). Age range: 39--80 years                                                                                                                     Acute myocardial infarction                       G1: Tai chi exercise\                                    Twice weekly for 3 weeks then weekly for a further 5 weeks   Physiological outcomes (blood pressure, heart rate)                                                                                                                                        8 weeks
                                                                                                                                                                                                                                                                                                                  G2: Aerobic exercise                                                                                                                                                                                                                                                                                             

  Chen (2006)[26](#jah31353-bib-0026){ref-type="ref"}            China              40 participants (G1=20, G2=20). Mean age: G1=64.3 years, G2=60.7. Mean duration of disease (SD): G1=8.4 years (4.9), G2=7.8 years (5.4)                                     Hypertension                                      G1: Tai chi plus drug\                                   7 times a week for 9 weeks                                   Physiological outcomes (blood pressure), biochemical outcomes (endothelin)                                                                                                                 10 weeks
                                                                                                                                                                                                                                                                                                                  G2: Drug                                                                                                                                                                                                                                                                                                         

  Chen (2013)[27](#jah31353-bib-0027){ref-type="ref"}            China              68 participants (G1=50, G2=18). Age range: 30--82 years                                                                                                                     Hypertension                                      G1: Conventional treatment and tai chi\                  6 times a week for 12 weeks                                  Physiological outcomes (blood pressure)                                                                                                                                                    12 weeks
                                                                                                                                                                                                                                                                                                                  G2: Conventional treatment                                                                                                                                                                                                                                                                                       

  Chen (2013)[28](#jah31353-bib-0028){ref-type="ref"}            China              60 participants (G1=32, G2=28). Mean age (SD): G1=69.3 years (10.6), G2=68.7 years (11.1)                                                                                   Coronary disease                                  G1: Conventional treatment and tai chi\                  4 times a week for 12 weeks                                  Biochemical outcomes (TC, TG, LDL‐C, HDL‐C)                                                                                                                                                12 weeks
                                                                                                                                                                                                                                                                                                                  G2: Conventional treatment                                                                                                                                                                                                                                                                                       

  Cheung (2005)[29](#jah31353-bib-0029){ref-type="ref"}          Hong Kong, China   88 participants (G1=47, G2=41). Mean age (SD): G1=57.2 years (9.5), G2=51.2 years (7.4). Mean duration of disease (SD): G1=4.0 years (5.6), G2=3.9 years (5.1)              Hypertension                                      G1: Qigong exercise\                                     4 hours a week for 16 weeks                                  Physiological outcomes (blood pressure, heart rate), biochemical outcomes (TC, TG, LDL‐C, HDL‐C), QOL (SF‐36), depression (Beck Depression Inventory)                                      4 weeks\
                                                                                                                                                                                                                                                                                                                  G2: conventional exercise                                                                                                                                                                                                                                                                                        8 weeks\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   12 weeks\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   16 weeks

  Ding (2013)[30](#jah31353-bib-0030){ref-type="ref"}            China              90 participants (G1=30, G2=30, G3=30). Mean age (SD): G1=66.2 years (11.6), G2=64.9 years (11.0), G3=66.7 years (13.1)                                                      Percutaneous transluminal coronary intervention   G1: Tai chi exercise\                                    5 times a week for 6 months                                  QOL (SF‐36)                                                                                                                                                                                6 weeks\
                                                                                                                                                                                                                                                                                                                  G2: Walking\                                                                                                                                                                                                                                                                                                     6 months
                                                                                                                                                                                                                                                                                                                  G3: No intervention                                                                                                                                                                                                                                                                                              

  Gemmell (2006)[31](#jah31353-bib-0031){ref-type="ref"}         New Zealand        18 participants (G1=9, G2=9)                                                                                                                                                Braumatic brain injury                            G1: TCE (tai chi)\                                       Once a week for 6 weeks                                      QOL (SF‐36)                                                                                                                                                                                6 weeks
                                                                                                                                                                                                                                                                                                                  G2: No intervention                                                                                                                                                                                                                                                                                              

  Hart (2004)[32](#jah31353-bib-0032){ref-type="ref"}            Israel             152 participants (G1=56, G2=55, G3=41). Mean age (SD): G1=70.8 years (6.3), G2=70 years (6.3), G3=69.6 years (6.1)                                                          Stroke                                            G1: TCE (tai chi)\                                       Twice a week for 12 weeks                                    QOL (Duke Health Profile)                                                                                                                                                                  6 weeks\
                                                                                                                                                                                                                                                                                                                  G2: Hydrotherapy\                                                                                                                                                                                                                                                                                                12 weeks
                                                                                                                                                                                                                                                                                                                  G3: No intervention                                                                                                                                                                                                                                                                                              

  Lee (2003)[33](#jah31353-bib-0033){ref-type="ref"}             Korea              58 participants (G1=29, G2=29). Mean age (SD): G1=55.8 years (6.3), G2=57.1 years (7.6)                                                                                     Hypertension                                      G1: Qigong exercise\                                     7 times a week for 10 weeks                                  Physiological outcomes (blood pressure, heart rate)                                                                                                                                        10 weeks
                                                                                                                                                                                                                                                                                                                  G2: No intervention                                                                                                                                                                                                                                                                                              

  Lee (2003)[34](#jah31353-bib-0034){ref-type="ref"}             Korea              58 participants (G1=29, G2=29). Mean age (SD): G1=56.0 years (5.9), G2=56.5 years (7.2)                                                                                     Hypertension                                      G1: Qigong exercise\                                     3 times a week for 10 weeks                                  Physiological outcomes (blood pressure, heart rate)                                                                                                                                        10 weeks
                                                                                                                                                                                                                                                                                                                  G2: No intervention                                                                                                                                                                                                                                                                                              

  Lee (2004)[35](#jah31353-bib-0035){ref-type="ref"}             Korea              36 participants (G1=17, G2=19). Mean age (SD): G1=52.6 years (5.1), G2=54.3 years (5.5)                                                                                     Hypertension                                      G1: Qigong exercise\                                     7 times a week for 8 weeks                                   Physiological outcomes (blood pressure), biochemical outcomes (TC, TG, HDL‐C)                                                                                                              8 weeks
                                                                                                                                                                                                                                                                                                                  G2: No intervention                                                                                                                                                                                                                                                                                              

  Li (2012)[36](#jah31353-bib-0036){ref-type="ref"}              China              68 participants (G1=36, G2=32). Age range: 38--76 years                                                                                                                     Stroke                                            G1: Tai chi exercise\                                    Twice weekly for 5 weeks                                     Depression (HAMD)                                                                                                                                                                          5 weeks
                                                                                                                                                                                                                                                                                                                  G2: Strength exercise                                                                                                                                                                                                                                                                                            

  Lin (2012)[37](#jah31353-bib-0037){ref-type="ref"}             China              60 participants (G1=30, G2=30). Mean age (SD): G1=66.47 years (8.26) G2=64.90 years (8.87)                                                                                  Coronary artery bypass grafting                   G1: Baduanjin\                                           4--5 times a week for 23 weeks                               QOL                                                                                                                                                                                        8 weeks\
                                                                                                                                                                                                                                                                                                                  G2: Conventional exercise                                                                                                                                                                                                                                                                                        20 weeks

  Luo (2006)[38](#jah31353-bib-0038){ref-type="ref"}             China              84 participants (G1=44, G2=40). Mean age (SD): G1=44.74 years (12.1), G2=44.86 years (13.05)                                                                                Hypertension                                      G1: Tai chi plus drug\                                   7 times a week for 6 months                                  Physiological outcomes (blood pressure)                                                                                                                                                    6 months
                                                                                                                                                                                                                                                                                                                  G2: Drug                                                                                                                                                                                                                                                                                                         

  Mao (2006)[39](#jah31353-bib-0039){ref-type="ref"}             China              62 participants (G1=51, G2=11). Mean age: G1=62.2 years, G2=63.3                                                                                                            Hypertension                                      G1: Tai chi exercise\                                    6 times a week for 8 weeks                                   Physiological outcomes (blood pressure), biochemical outcomes (endothelin, no)                                                                                                             8 weeks
                                                                                                                                                                                                                                                                                                                  G2: Drug                                                                                                                                                                                                                                                                                                         

  Ning (2010)[40](#jah31353-bib-0040){ref-type="ref"}            China              50 participants (G1=26, G2=24). Mean age (SD): G1=53.9 years (6.4), G2=53.5 years (6.7)                                                                                     Coronary disease                                  G1: Tai chi exercise\                                    2 or 3 times a week for 6 months                             Biochemical outcomes (TC, TG)                                                                                                                                                              8 weeks
                                                                                                                                                                                                                                                                                                                  G2: Drug                                                                                                                                                                                                                                                                                                         

  Pan (2009) [41](#jah31353-bib-0041){ref-type="ref"}            China              48 participants (G1=24, G2=24). Mean age (SD): G1=62.1 years (5.8), G2=61.4 years (7.1)                                                                                     Hypertension                                      G1: Baduanjin exercise plus drug\                        5 times a week for 24 weeks                                  Physiological outcomes (blood pressure), biochemical outcomes (TC, TG, HDL‐C)                                                                                                              24 weeks
                                                                                                                                                                                                                                                                                                                  G2: Drug                                                                                                                                                                                                                                                                                                         

  Sato (2010)[42](#jah31353-bib-0042){ref-type="ref"}            Japan              20 participants (G1=10, G2=10). Mean age (SD): G1=68 years (5), G2=68 years (4). Mean duration of disease (SD): G1=19 months (15), G2=21 months (13)                        Coronary disease                                  G1: Tai chi exercise plus conventional rehabilitation\   4 times a week for 1 year                                    Physiological outcomes (peak oxygen uptake, blood pressure, heart rate)                                                                                                                    1 year
                                                                                                                                                                                                                                                                                                                  G2: Conventional rehabilitation                                                                                                                                                                                                                                                                                  

  Taylor‐Piliae (2012)[43](#jah31353-bib-0043){ref-type="ref"}   USA                28 participants (G1=16, G2=12). Mean age (SD): G1=72.8 years (10.1), G2=64.5 years (10.9). Mean duration of disease (SD): G1=58.3 months (46.7), G2=47.9 months (42.5)      Chronic stroke                                    G1: Tai chi\                                             Once a week for 8 weeks                                      Physical function (Short Physical Performance Battery), QOL (SF‐36)                                                                                                                        8 weeks
                                                                                                                                                                                                                                                                                                                  G2: Usual care                                                                                                                                                                                                                                                                                                   

  Tsai (2003)[44](#jah31353-bib-0044){ref-type="ref"}            Taiwan, China      76 participants (G1=37, G2=39). Mean age (SD): G1=50.5 years (7), G2=62.7 years (4)                                                                                         Hypertension                                      G1: TCE (tai chi chuan)\                                 3 times a week for 12 weeks                                  Physiological outcomes (blood pressure, heart rate), biochemical outcomes (TC, TG, LDL‐C, HDL‐C)                                                                                           12 weeks
                                                                                                                                                                                                                                                                                                                  G2: Sedentary life controls                                                                                                                                                                                                                                                                                      

  Wang (1989)[45](#jah31353-bib-0045){ref-type="ref"}            China              100 participants (G1=50, G2=50). Age range: 45--65                                                                                                                          Hypertension                                      G1: Qigong exercise plus drug\                           7 times a week for 1 year                                    Biochemical outcomes (TC, TG, LDL‐C, HDL‐C)                                                                                                                                                1 year
                                                                                                                                                                                                                                                                                                                  G2: Drug                                                                                                                                                                                                                                                                                                         

  Wang (2010)[46](#jah31353-bib-0046){ref-type="ref"}            Japan              34 participants (G1=17, G2=17). Age: \>50 years                                                                                                                             Cerebral vascular disorder                        G1: TCE (tai chi)\                                       Once a week for 12 weeks                                     QOL (GHQ), depressing (GHQ)                                                                                                                                                                12 weeks
                                                                                                                                                                                                                                                                                                                  G2: Rehabilitation exercise                                                                                                                                                                                                                                                                                      

  Wang (2012)[47](#jah31353-bib-0047){ref-type="ref"}            China              69 participants (G1=36, G2=33). Mean age (SD): G1=55.8 years (3.54), G2=51.2 years (7.8)                                                                                    Stroke                                            G1: Tai chi exercise\                                    2 times a week for 3 months                                  QOL (SF‐36) and depression (HAMD)                                                                                                                                                          6 months
                                                                                                                                                                                                                                                                                                                  G2: Conventional exercise                                                                                                                                                                                                                                                                                        

  Wang (2013)[48](#jah31353-bib-0048){ref-type="ref"}            China              60 participants (G1=30, G2=30). Mean age (SD): G1=55.25 years (11.13), G2=54.86 years (12.05)                                                                               Percutaneous transluminal coronary intervention   G1: Conventional treatment and tai chi\                  5 times a week for 6 months                                  QOL (SF‐36)                                                                                                                                                                                3 months 6 months
                                                                                                                                                                                                                                                                                                                  G2: Conventional treatment                                                                                                                                                                                                                                                                                       

  Yao (2010)[49](#jah31353-bib-0049){ref-type="ref"}             China              150 participants (G1=80, G2=70). Mean age (SD): G1=52.4 years (6.32), G2=51.7 years (7.26)                                                                                  Chronic heart failure                             G1: Conventional treatment and tai chi\                  \>5 times a week for 6 months                                Physical function (6MWT), quality of life (SF‐36)                                                                                                                                          6 months
                                                                                                                                                                                                                                                                                                                  G2: Conventional treatment                                                                                                                                                                                                                                                                                       

  Yeh (2004)[50](#jah31353-bib-0050){ref-type="ref"}             USA                30 participants (G1=15, G2=15). Mean age (SD): G1=66 years (12), G2=61 years (14)                                                                                           Chronic heart failure                             G1: Usual care and tai chi exercise\                     Twice weekly for 12 weeks                                    Physiological outcomes (peak oxygen uptake), biochemical outcomes (BNP), physical function (6MWT), QOL (MLHFQ)                                                                             12 weeks
                                                                                                                                                                                                                                                                                                                  G2: Usual care                                                                                                                                                                                                                                                                                                   

  Yeh (2008)[51](#jah31353-bib-0051){ref-type="ref"}             USA                18 participants (G1=8, G2=10). Mean age (SD): G1=54.7 years (11.8), G2=64.2 years (16.2)                                                                                    Chronic heart failure                             G1: Tai chi exercise and usual care\                     Twice weekly for 12 weeks                                    Biochemical outcomes (BNP), physical function (6MWT), quality of life (MLHFQ)                                                                                                              12 weeks
                                                                                                                                                                                                                                                                                                                  G2: Usual care                                                                                                                                                                                                                                                                                                   

  Yeh (2011)[52](#jah31353-bib-0052){ref-type="ref"}             USA                100 participants (G1=50, G2=50). Mean age (SD): G1=68.1 years (11.9), G2=66.6 years (12.1)                                                                                  Chronic heart failure                             G1: Usual care and tai chi exercise\                     Twice weekly for 12 weeks                                    Physiological outcomes (peak oxygen uptake), biochemical outcomes (BNP), physical function (timed up and go, 6MWT), QOL (MLHFQ), depression (POMS)                                         12 weeks
                                                                                                                                                                                                                                                                                                                  G2: Usual care and education sessions                                                                                                                                                                                                                                                                            

  Yeh (2013)[53](#jah31353-bib-0053){ref-type="ref"}             USA                16 participants (G1=8, G2=8). Mean age (SD): G1=68 years (11), G2=63 years (11)                                                                                             Heart failure                                     G1: Tai chi exercise\                                    Twice weekly for 12 weeks                                    Physiological outcomes (blood pressure, Peak oxygen uptake, heart rate), biochemical outcomes (BNP), physical function (time up and go, 6MWT), quality of life (MLHF), depression (POMS)   12 weeks
                                                                                                                                                                                                                                                                                                                  G2: Aerobic exercise                                                                                                                                                                                                                                                                                             

  Yu (2013)[54](#jah31353-bib-0054){ref-type="ref"}              China              104 participants (G1=52, G2=52). Age range: 40--70 years                                                                                                                    Hypertension                                      G1: Baduanjin exercise plus education\                   3 or 4 times a week for 1 year                               Blood pressure                                                                                                                                                                             1 year
                                                                                                                                                                                                                                                                                                                  G2: Education                                                                                                                                                                                                                                                                                                    

  Zhang (2013)[55](#jah31353-bib-0055){ref-type="ref"}           China              120 participants (G1=60, G2=60). Mean age: G1=73.9 years, G2=76.5 years                                                                                                     Hypertension                                      G1: Baduanjin exercise plus drug\                        7 times a week for 2 months                                  QOL                                                                                                                                                                                        2 months
                                                                                                                                                                                                                                                                                                                  G2: Drug                                                                                                                                                                                                                                                                                                         
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

6MWT indicates 6‐minute walk test; BNP, B‐type natriuretic peptide; G, group; GHQ, General Health Questionnaire; HAMD, Hamilton Depression Rating Scale; HDL‐C, high‐density lipoprotein cholesterol; LDL‐C, low‐density lipoprotein cholesterol; MLHFQ, Minnesota Living With Heart Failure Questionnaire; POMS, Profile of Mood States; QOL, quality of life; SCL‐R, Symptom Checklist 90--Revised; SF‐36, 36‐Item Short Form; TC, total cholesterol; TCE, traditional Chinese exercise; TG, triglyceride; WHOQOL‐BREF, World Health Organization Quality of Life project 26‐item instrument.
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Risk of Bias Among the Selected Articles {#jah31353-sec-0014}
----------------------------------------

We assessed the risk of bias in all selected articles (Table [2](#jah31353-tbl-0002){ref-type="table-wrap"}). All articles used the generation of the allocation sequence (n=35, 100%). Allocation concealment was inadequate in most articles (n=26, 74%). None of the studies blinded their participants or personnel. Eight articles (23%) masked their outcome assessors to the treatment allocation. A low risk of incomplete outcome bias was reported in 31 articles (88.5%), whereas a low risk of selective reporting bias was reported in most articles (n=28, 73.6%).

###### 

Risk of Bias Assessment of Included Studies

  Article, Year                                                  Random Sequence Generation   Allocation Concealment   Blinding of Participants and Personnel   Blinding of Outcome Assessment   Incomplete Outcome Data   Selective Reporting   Other Bias
  -------------------------------------------------------------- ---------------------------- ------------------------ ---------------------------------------- -------------------------------- ------------------------- --------------------- ------------
  Barrow (2007)[21](#jah31353-bib-0021){ref-type="ref"}          Low                          High                     High                                     High                             Low                       Low                   Unclear
  Blake (2009)[22](#jah31353-bib-0022){ref-type="ref"}           Low                          Low                      High                                     High                             Low                       Low                   Unclear
  Cai (2010)[23](#jah31353-bib-0023){ref-type="ref"}             Low                          High                     High                                     High                             Low                       Low                   Unclear
  Caminiti (2011)[24](#jah31353-bib-0024){ref-type="ref"}        Low                          High                     High                                     High                             Low                       Low                   Unclear
  Channer (1996)[25](#jah31353-bib-0025){ref-type="ref"}         Low                          High                     High                                     High                             Low                       Low                   Unclear
  Chen (2006)[26](#jah31353-bib-0026){ref-type="ref"}            Low                          High                     High                                     High                             Low                       Low                   Unclear
  Chen (2013)[27](#jah31353-bib-0027){ref-type="ref"}            Low                          High                     High                                     High                             Low                       Low                   Unclear
  Chen (2013)[28](#jah31353-bib-0028){ref-type="ref"}            Low                          High                     High                                     High                             Low                       Low                   Unclear
  Cheung (2005)[29](#jah31353-bib-0029){ref-type="ref"}          Low                          Low                      High                                     Low                              Low                       Low                   Unclear
  Ding (2013)[30](#jah31353-bib-0030){ref-type="ref"}            Low                          High                     High                                     High                             Low                       Low                   Unclear
  Gemmell (2006)[31](#jah31353-bib-0031){ref-type="ref"}         Low                          High                     High                                     Low                              Low                       Low                   Unclear
  Hart (2004)[32](#jah31353-bib-0032){ref-type="ref"}            Low                          High                     High                                     High                             Low                       Low                   Unclear
  Lee (2003)[33](#jah31353-bib-0033){ref-type="ref"}             Low                          High                     High                                     High                             Unclear                   Unclear               Unclear
  Lee (2003)[34](#jah31353-bib-0034){ref-type="ref"}             Low                          Low                      High                                     High                             Unclear                   Unclear               Unclear
  Lee (2004)[35](#jah31353-bib-0035){ref-type="ref"}             Low                          High                     High                                     High                             Low                       Unclear               Unclear
  Li (2012)[36](#jah31353-bib-0036){ref-type="ref"}              Low                          High                     High                                     High                             Low                       Low                   Unclear
  Lin (2012)[37](#jah31353-bib-0037){ref-type="ref"}             Low                          High                     High                                     High                             Low                       Low                   Unclear
  Luo (2006)[38](#jah31353-bib-0038){ref-type="ref"}             Low                          High                     High                                     High                             Low                       Low                   Unclear
  Mao (2006)[39](#jah31353-bib-0039){ref-type="ref"}             Low                          High                     High                                     High                             Low                       Low                   Unclear
  Ning (2010)[40](#jah31353-bib-0040){ref-type="ref"}            Low                          High                     High                                     High                             Low                       Low                   Unclear
  Pan (2009)[41](#jah31353-bib-0041){ref-type="ref"}             Low                          Low                      High                                     High                             Low                       Low                   Unclear
  Sato (2010)[42](#jah31353-bib-0042){ref-type="ref"}            Low                          High                     High                                     High                             Low                       Low                   Unclear
  Taylor‐Piliae (2012)[43](#jah31353-bib-0043){ref-type="ref"}   Low                          Low                      High                                     Low                              Low                       Low                   Unclear
  Tsai (2003)[44](#jah31353-bib-0044){ref-type="ref"}            Low                          Low                      High                                     Low                              Low                       Low                   Unclear
  Wang (1989)[45](#jah31353-bib-0045){ref-type="ref"}            Low                          High                     High                                     High                             Low                       Low                   Unclear
  Wang (2010)[46](#jah31353-bib-0046){ref-type="ref"}            Low                          High                     High                                     Low                              Low                       Low                   Unclear
  Wang (2012)[47](#jah31353-bib-0047){ref-type="ref"}            Low                          High                     High                                     High                             Unclear                   Low                   Unclear
  Wang (2013)[48](#jah31353-bib-0048){ref-type="ref"}            Low                          High                     High                                     High                             Low                       Low                   Unclear
  Yao (2010)[49](#jah31353-bib-0049){ref-type="ref"}             Low                          High                     High                                     High                             Low                       Low                   Unclear
  Yeh (2004)[50](#jah31353-bib-0050){ref-type="ref"}             Low                          Low                      High                                     Low                              Low                       Unclear               Unclear
  Yeh (2008)[51](#jah31353-bib-0051){ref-type="ref"}             Low                          High                     High                                     High                             Unclear                   Unclear               Unclear
  Yeh (2011)[52](#jah31353-bib-0052){ref-type="ref"}             Low                          Low                      High                                     Low                              Low                       Unclear               Unclear
  Yeh (2013)[53](#jah31353-bib-0053){ref-type="ref"}             Low                          Low                      High                                     Low                              Low                       Unclear               Unclear
  Yu (2013)[54](#jah31353-bib-0054){ref-type="ref"}              Low                          High                     High                                     High                             Low                       Low                   Unclear
  Zhang (2013)[55](#jah31353-bib-0055){ref-type="ref"}           Low                          High                     High                                     High                             Low                       Low                   Unclear
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Effects of TCE on Physiological Outcomes {#jah31353-sec-0015}
----------------------------------------

### Blood pressure {#jah31353-sec-0016}

Sixteen articles[\*](#jah31353-note-0103){ref-type="fn"} involving 939 patients compared the systolic blood pressures (SBPs) and diastolic blood pressures (DBPs) between patients performing TCEs and those in the control group. Based on a random‐effects model, TCE was found to decrease SBP by 9.12 mm Hg (95% CI −16.38 to −1.86, *P*=0.01; I^2^=99%, *P*\<0.00001) and DBP by 5.12 mm Hg (95% CI −7.71 to −2.52, *P*\<0.001; I^2^=97%, *P*\<0.00001) among patients performing TCEs compared with those in the control group (Figure [2](#jah31353-fig-0002){ref-type="fig"} and Table [3](#jah31353-tbl-0003){ref-type="table-wrap"}).

![Meta‐analysis of effects of traditional Chinese exercise on blood pressure: (A) systolic blood pressure, (B) diastolic blood pressure. IV, inverse variance; Std., standardized; TCE, traditional Chinese exercise.](JAH3-5-e002562-g002){#jah31353-fig-0002}

###### 

Summary of Results

  Outcome                        Trials                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             Participants   Statistical Method         Effect Estimate               Heterogeneity   *P* Value
  ------------------------------ -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------- -------------------------- ----------------------------- --------------- -----------
  Physiological outcomes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
  SBP, mm Hg                     16[21](#jah31353-bib-0021){ref-type="ref"}, [24](#jah31353-bib-0024){ref-type="ref"}, [25](#jah31353-bib-0025){ref-type="ref"}, [26](#jah31353-bib-0026){ref-type="ref"}, [27](#jah31353-bib-0027){ref-type="ref"}, [29](#jah31353-bib-0029){ref-type="ref"}, [33](#jah31353-bib-0033){ref-type="ref"}, [34](#jah31353-bib-0034){ref-type="ref"}, [35](#jah31353-bib-0035){ref-type="ref"}, [38](#jah31353-bib-0038){ref-type="ref"}, [39](#jah31353-bib-0039){ref-type="ref"}, [41](#jah31353-bib-0041){ref-type="ref"}, [42](#jah31353-bib-0042){ref-type="ref"}, [44](#jah31353-bib-0044){ref-type="ref"}, [53](#jah31353-bib-0053){ref-type="ref"}, [54](#jah31353-bib-0054){ref-type="ref"}   939            MD (IV, random, 95% CI)    −9.12 \[−16.38 to −1.86\]     \<0.001         0.01
  DBP, mm Hg                     16[21](#jah31353-bib-0021){ref-type="ref"}, [24](#jah31353-bib-0024){ref-type="ref"}, [25](#jah31353-bib-0025){ref-type="ref"}, [26](#jah31353-bib-0026){ref-type="ref"}, [27](#jah31353-bib-0027){ref-type="ref"}, [29](#jah31353-bib-0029){ref-type="ref"}, [33](#jah31353-bib-0033){ref-type="ref"}, [34](#jah31353-bib-0034){ref-type="ref"}, [35](#jah31353-bib-0035){ref-type="ref"}, [38](#jah31353-bib-0038){ref-type="ref"}, [39](#jah31353-bib-0039){ref-type="ref"}, [41](#jah31353-bib-0041){ref-type="ref"}, [42](#jah31353-bib-0042){ref-type="ref"}, [44](#jah31353-bib-0044){ref-type="ref"}, [53](#jah31353-bib-0053){ref-type="ref"}, [54](#jah31353-bib-0054){ref-type="ref"}   939            MD (IV, random, 95% CI)    −5.12 \[−7.71 to −2.52\]      \<0.001         \<0.001
  Heart rate, beats per minute   9[24](#jah31353-bib-0024){ref-type="ref"}, [25](#jah31353-bib-0025){ref-type="ref"}, [29](#jah31353-bib-0029){ref-type="ref"}, [33](#jah31353-bib-0033){ref-type="ref"}, [34](#jah31353-bib-0034){ref-type="ref"}, [42](#jah31353-bib-0042){ref-type="ref"}, [44](#jah31353-bib-0044){ref-type="ref"}, [51](#jah31353-bib-0051){ref-type="ref"}, [53](#jah31353-bib-0053){ref-type="ref"}                                                                                                                                                                                                                                                                                                          463            MD (IV, random, 95% CI)    −2.39 \[−5.61 to 0.82\]       \<0.001         0.14
  Peak oxygen uptake, L/min      4[42](#jah31353-bib-0042){ref-type="ref"}, [50](#jah31353-bib-0050){ref-type="ref"}, [52](#jah31353-bib-0052){ref-type="ref"}, [53](#jah31353-bib-0053){ref-type="ref"}                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            166            SMD (IV, random, 95% CI)   0.04 \[−0.46 to 0.55\]        0.11            0.87
  Biochemical outcomes                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
  TG                             6[28](#jah31353-bib-0028){ref-type="ref"}, [29](#jah31353-bib-0029){ref-type="ref"}, [35](#jah31353-bib-0035){ref-type="ref"}, [41](#jah31353-bib-0041){ref-type="ref"}, [44](#jah31353-bib-0044){ref-type="ref"}, [45](#jah31353-bib-0045){ref-type="ref"}                                                                                                                                                                                                                                                                                                                                                                                                                                        408            SMD (IV, random, 95% CI)   −0.33 \[−0.56 to −0.09\]      0.23            0.006
  TC                             6[28](#jah31353-bib-0028){ref-type="ref"}, [29](#jah31353-bib-0029){ref-type="ref"}, [35](#jah31353-bib-0035){ref-type="ref"}, [41](#jah31353-bib-0041){ref-type="ref"}, [44](#jah31353-bib-0044){ref-type="ref"}, [45](#jah31353-bib-0045){ref-type="ref"}                                                                                                                                                                                                                                                                                                                                                                                                                                        408            SMD (IV, random, 95% CI)   −1.12 \[−1.97 to −0.27\]      \<0.001         0.01
  LDL‐C                          4[28](#jah31353-bib-0028){ref-type="ref"}, [29](#jah31353-bib-0029){ref-type="ref"}, [44](#jah31353-bib-0044){ref-type="ref"}, [45](#jah31353-bib-0045){ref-type="ref"}                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            324            SMD (IV, random, 95% CI)   −0.81 \[−1.24 to −0.38\]      0.02            \<0.001
  HDL‐C                          6[28](#jah31353-bib-0028){ref-type="ref"}, [29](#jah31353-bib-0029){ref-type="ref"}, [35](#jah31353-bib-0035){ref-type="ref"}, [41](#jah31353-bib-0041){ref-type="ref"}, [44](#jah31353-bib-0044){ref-type="ref"}, [45](#jah31353-bib-0045){ref-type="ref"}                                                                                                                                                                                                                                                                                                                                                                                                                                        408            SMD (IV, random, 95% CI)   0.74 \[0.29--1.18\]           \<0.001         0.001
  BNP, ng ⁄ mL                   3[50](#jah31353-bib-0050){ref-type="ref"}, [52](#jah31353-bib-0052){ref-type="ref"}, [53](#jah31353-bib-0053){ref-type="ref"}                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      146            MD (IV, random, 95% CI)    −23.04 \[−27.10 to −18.98\]   0.73            \<0.001
  Physical function                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
  Timed up and go test, s        2[52](#jah31353-bib-0052){ref-type="ref"}, [53](#jah31353-bib-0053){ref-type="ref"}                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                116            MD (IV, random, 95% CI)    −0.20 \[−0.64 to 0.24\]       0.77            0.38
  6‐minute walk test, m          6[24](#jah31353-bib-0024){ref-type="ref"}, [49](#jah31353-bib-0049){ref-type="ref"}, [50](#jah31353-bib-0050){ref-type="ref"}, [51](#jah31353-bib-0051){ref-type="ref"}, [52](#jah31353-bib-0052){ref-type="ref"}, [53](#jah31353-bib-0053){ref-type="ref"}                                                                                                                                                                                                                                                                                                                                                                                                                                        374            MD (IV, random, 95% CI)    59.58 \[4.95--114.20\]        \<0.001         0.03
  Quality of life                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
  MLHFQ                          5[21](#jah31353-bib-0021){ref-type="ref"}, [50](#jah31353-bib-0050){ref-type="ref"}, [51](#jah31353-bib-0051){ref-type="ref"}, [52](#jah31353-bib-0052){ref-type="ref"}, [53](#jah31353-bib-0053){ref-type="ref"}                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  216            MD (IV, random, 95% CI)    −17.08 \[−23.74 to −10.41\]   0.02            \<0.001
  GHQ                            2[22](#jah31353-bib-0022){ref-type="ref"}, [46](#jah31353-bib-0046){ref-type="ref"}                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                49             MD (IV, random, 95% CI)    −1.02 \[−2.91 to 0.87\]       0.19            0.29
  SF‐36, total                   2[30](#jah31353-bib-0030){ref-type="ref"}, [49](#jah31353-bib-0049){ref-type="ref"}                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                148            MD (IV, random, 95% CI)    −5.95 \[−16.16 to 4.27\]      0.02            0.25
  SF‐36, general health          3[29](#jah31353-bib-0029){ref-type="ref"}, [31](#jah31353-bib-0031){ref-type="ref"}, [49](#jah31353-bib-0049){ref-type="ref"}                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      126            MD (IV, random, 95% CI)    −1.56 \[−2.52 to −0.61\]      0.4             0.001
  SF‐36, physical function       3[29](#jah31353-bib-0029){ref-type="ref"}, [31](#jah31353-bib-0031){ref-type="ref"}, [43](#jah31353-bib-0043){ref-type="ref"}                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      131            MD (IV, random, 95% CI)    0.82 \[0.32--1.33\]           0.45            0.001
  SF‐36, mental health           3[29](#jah31353-bib-0029){ref-type="ref"}, [31](#jah31353-bib-0031){ref-type="ref"}, [43](#jah31353-bib-0043){ref-type="ref"}                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      131            MD (IV, random, 95% CI)    −2.67 \[−10.08 to 4.75\]      0.09            0.48
  Depression                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
  HAMD                           2[36](#jah31353-bib-0036){ref-type="ref"}, [47](#jah31353-bib-0047){ref-type="ref"}                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                129            MD (IV, random, 95% CI)    −3.97 \[−5.05 to −2.89\]      0.91            \<0.001
  POMS depression scale          2[52](#jah31353-bib-0052){ref-type="ref"}, [53](#jah31353-bib-0053){ref-type="ref"}                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                116            MD (IV, random, 95% CI)    −3.02 \[−3.50 to −2.53\]      0.76            \<0.001

BNP indicates B‐type natriuretic peptide; DBP, diastolic blood pressure; GHQ, General Health Questionnaire; HAMD, Hamilton Depression Rating Scale; HDL‐C, high‐density lipoprotein cholesterol; IV, inverse variance; LDL‐C, low‐density lipoprotein cholesterol; MD, mean difference; MLHFQ, Minnesota Living With Heart Failure Questionnaire; POMS, Profile of Mood States; SBP, systolic blood pressure; SF‐36, 36‐Item Short Form; SMD, standardized mean difference; TC, total cholesterol; TG, triglyceride.
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### Heart rate {#jah31353-sec-0017}

Nine articles[\*\*](#jah31353-note-0104){ref-type="fn"} involving 463 patients compared the heart rate between patients performing TCEs and those in the control group. No significant differences were observed between the 2 groups based on a random‐effects model (MD −2.39 beats per minute, 95% CI −5.61 to −0.82, *P*=0.14) (Table [3](#jah31353-tbl-0003){ref-type="table-wrap"}).

### Peak oxygen uptake {#jah31353-sec-0018}

Four articles[42](#jah31353-bib-0042){ref-type="ref"}, [50](#jah31353-bib-0050){ref-type="ref"}, [52](#jah31353-bib-0052){ref-type="ref"}, [53](#jah31353-bib-0053){ref-type="ref"} involving 166 patients compared the peak oxygen uptake of patients performing TCEs and those in the control group. The peak oxygen uptake of patients performing TCEs did not increase significantly compared with that of the patients in the control group, based on a random‐effects model (SMD 0.04, 95% CI −0.46 to 0.55, *P*=0.87) (Table [3](#jah31353-tbl-0003){ref-type="table-wrap"}).

Sensitivity analysis revealed that the pooled results of SBP, DBP, and peak oxygen uptake did not change statistical significance of the overall analysis when studies were removed 1 by 1. When 1 study[24](#jah31353-bib-0024){ref-type="ref"} was removed, however, the result of heart rate was significant in the sensitivity analysis; it offered inferior evidence for the effect of TCE on heart rate. The sensitivity analysis did not affect heterogeneity of blood pressure, heart rate, or peak oxygen uptake outcomes.

Effects of TCE on Biochemical Outcomes {#jah31353-sec-0019}
--------------------------------------

### Triglyceride {#jah31353-sec-0020}

Six articles[28](#jah31353-bib-0028){ref-type="ref"}, [29](#jah31353-bib-0029){ref-type="ref"}, [35](#jah31353-bib-0035){ref-type="ref"}, [41](#jah31353-bib-0041){ref-type="ref"}, [44](#jah31353-bib-0044){ref-type="ref"}, [45](#jah31353-bib-0045){ref-type="ref"} involving 408 patients compared the TG levels of patients performing TCEs and those in the control group. Based on a random‐effects model, the TG levels of patients performing TCEs significantly decreased (SMD −0.33, 95% CI −0.56 to −0.09, *P*=0.006; I^2^=28%, *P*=0.23) compared with those of the patients in the control group (Figure [3](#jah31353-fig-0003){ref-type="fig"}A and Table [3](#jah31353-tbl-0003){ref-type="table-wrap"}).

![Meta‐analysis of effects of traditional Chinese exercise on biochemical outcomes: (A) triglyceride, (B) total cholesterol, (C) low‐density lipoprotein cholesterol, (D) high‐density lipoprotein cholesterol. IV, inverse variance; TCE, traditional Chinese exercise.](JAH3-5-e002562-g003){#jah31353-fig-0003}

### Total cholesterol {#jah31353-sec-0021}

Six articles[28](#jah31353-bib-0028){ref-type="ref"}, [29](#jah31353-bib-0029){ref-type="ref"}, [35](#jah31353-bib-0035){ref-type="ref"}, [41](#jah31353-bib-0041){ref-type="ref"}, [44](#jah31353-bib-0044){ref-type="ref"}, [45](#jah31353-bib-0045){ref-type="ref"} involving 408 patients were included to estimate the effect of TCEs on the amount of total cholesterol (TC). TC of the patients performing TCEs significantly improved (SMD −1.12, 95% CI −1.97 to −0.27, *P*=0.01; I^2^=93%, *P*\<0.00001) compared with that of the patients in the control group based on a random‐effects model (Figure [3](#jah31353-fig-0003){ref-type="fig"}B and Table [3](#jah31353-tbl-0003){ref-type="table-wrap"}).

### Low‐density lipoprotein cholesterol {#jah31353-sec-0022}

Four articles[28](#jah31353-bib-0028){ref-type="ref"}, [29](#jah31353-bib-0029){ref-type="ref"}, [44](#jah31353-bib-0044){ref-type="ref"}, [45](#jah31353-bib-0045){ref-type="ref"} involving 324 patients compared the low‐density lipoprotein cholesterol (LDL‐C) levels between patients performing TCEs and those in the control group. In a random‐effects model, the LDL‐C of patients performing TCEs significantly decreased (SMD −0.81, 95% CI −1.24 to −0.38, *P*\<0.001; I^2^=71%, *P*=0.02) compared with that of the patients in the control group (Figure [3](#jah31353-fig-0003){ref-type="fig"}C and Table [3](#jah31353-tbl-0003){ref-type="table-wrap"}).

### High‐density lipoprotein cholesterol {#jah31353-sec-0023}

Six articles[28](#jah31353-bib-0028){ref-type="ref"}, [29](#jah31353-bib-0029){ref-type="ref"}, [35](#jah31353-bib-0035){ref-type="ref"}, [41](#jah31353-bib-0041){ref-type="ref"}, [44](#jah31353-bib-0044){ref-type="ref"}, [45](#jah31353-bib-0045){ref-type="ref"} involving 408 patients were included in the meta‐analysis to assess the effect of TCE on HDL‐C. The HDL‐C of patients performing TCEs significantly improved (SMD 0.74, 95% CI 0.29--1.18, *P*=0.001; I^2^=79%, *P*=0.0003) compared with that of the patients in the control group based on a random‐effects model (Figure [3](#jah31353-fig-0003){ref-type="fig"}D and Table [3](#jah31353-tbl-0003){ref-type="table-wrap"}).

### B‐type natriuretic peptide {#jah31353-sec-0024}

Three articles[50](#jah31353-bib-0050){ref-type="ref"}, [52](#jah31353-bib-0052){ref-type="ref"}, [53](#jah31353-bib-0053){ref-type="ref"} involving 146 patients compared the B‐type natriuretic peptide (BNP) of patients performing TCEs and those in the control group. Based on a random‐effects model, the BNP of the patients performing TCEs significantly improved (MD −23.04 ng/mL, 95% CI −27.10 to −18.98, *P*\<0.001) compared with that of the patients in the control group (Table [3](#jah31353-tbl-0003){ref-type="table-wrap"}).

Sensitivity analysis revealed that TG, TC, LDL‐C, and HDL‐C outcomes were stable when studies were removed 1 by 1. The significance of the BNP outcome was changed in the sensitivity analysis when 1 study[52](#jah31353-bib-0052){ref-type="ref"} was removed; this result offered inferior evidence for the effect of TCE on BNP. The sensitivity analysis did not affect heterogeneity of TG, TC, LDL‐C, HDL‐C and BNP outcomes.

Effects of TCE on Physical Function {#jah31353-sec-0025}
-----------------------------------

### Timed up and go test {#jah31353-sec-0026}

Two articles[52](#jah31353-bib-0052){ref-type="ref"}, [53](#jah31353-bib-0053){ref-type="ref"} involving 116 patients compared the timed up and go tests of patients performing TCEs and those in the control group. No significant difference was found between the 2 groups (MD −0.2 second, 95% CI −0.64 to 0.24, *P*=0.38) (Table [3](#jah31353-tbl-0003){ref-type="table-wrap"}).

### Six‐minute walk test {#jah31353-sec-0027}

Six articles[24](#jah31353-bib-0024){ref-type="ref"}, [49](#jah31353-bib-0049){ref-type="ref"}, [50](#jah31353-bib-0050){ref-type="ref"}, [51](#jah31353-bib-0051){ref-type="ref"}, [52](#jah31353-bib-0052){ref-type="ref"}, [53](#jah31353-bib-0053){ref-type="ref"} involving 374 patients were used to estimate the effect of TCE on 6‐minute walk test. The 6‐minute walk tests of patients performing TCEs improved by 59.58 m (95% CI 4.95--114.20, *P*=0.03; I^2^=93%, *P*\<0.00001) compared with that of the control group, based on a random‐effects model (Figure [4](#jah31353-fig-0004){ref-type="fig"}A and Table [3](#jah31353-tbl-0003){ref-type="table-wrap"}). Sensitivity analysis revealed that the 6‐minute walk test outcome was not stable when studies were removed 1 by 1. The sensitivity analysis did not affect heterogeneity of the timed up and go or 6‐minute walk test outcomes.

![Meta‐analysis of effects of traditional Chinese exercise on (A) 6‐minute walk test, (B) Minnesota Living with Heart Failure Questionnaire, and (C) Hamilton depression rating scales. IV, inverse variance; TCE, traditional Chinese exercise.](JAH3-5-e002562-g004){#jah31353-fig-0004}

Effects of TCE on Quality of Life {#jah31353-sec-0028}
---------------------------------

### Minnesota Living With Heart Failure Questionnaire {#jah31353-sec-0029}

Five articles[21](#jah31353-bib-0021){ref-type="ref"}, [50](#jah31353-bib-0050){ref-type="ref"}, [51](#jah31353-bib-0051){ref-type="ref"}, [52](#jah31353-bib-0052){ref-type="ref"}, [53](#jah31353-bib-0053){ref-type="ref"} involving 216 patients were included to assess the effect of TCE on MLHFQ. The MLHFQ scores of patients performing TCEs significantly improved (MD −17.08, 95% CI −23.74 to −10.41, *P*\<0.001; I^2^=67%, *P*=0.02) compared with that of the patients in the control group, based on a random effects model (Figure [4](#jah31353-fig-0004){ref-type="fig"}B and Table [3](#jah31353-tbl-0003){ref-type="table-wrap"}).

### General Health Questionnaire {#jah31353-sec-0030}

Two articles[22](#jah31353-bib-0022){ref-type="ref"}, [46](#jah31353-bib-0046){ref-type="ref"} involving 49 patients compared the GHQ scores of patients performing TCEs and those in the control group. No significant differences were found between these groups based on a random‐effects model (MD −1.02, 95% CI −2.91 to 0.87, *P*=0.29; I^2^=43%, *P*=0.29) (Table [3](#jah31353-tbl-0003){ref-type="table-wrap"}).

### 36‐Item Short Form {#jah31353-sec-0031}

Five articles[29](#jah31353-bib-0029){ref-type="ref"}, [30](#jah31353-bib-0030){ref-type="ref"}, [31](#jah31353-bib-0031){ref-type="ref"}, [43](#jah31353-bib-0043){ref-type="ref"}, [46](#jah31353-bib-0046){ref-type="ref"}, [49](#jah31353-bib-0049){ref-type="ref"} involving 374 patients were used to estimate the effect of TCE on SF‐36. Compared with the patients in the control group, those performing TCEs showed improved SF‐36 general health results (MD −1.56, 95% CI −2.52 to −0.61, *P*=0.001; I^2^=0%, *P*=0.4) and SF‐36 physical function (MD 0.82, 95% CI 0.32--1.33, *P*=0.001; I^2^=0%, *P*=0.45). No significant differences were found between the 2 groups in terms of SF‐36 total score (MD −5.95, 95% CI −16.16 to 4.27, *P*=0.25; I^2^=82%, *P*=0.02) and SF‐36 mental health results (MD −2.67, 95% CI −10.08 to 4.75, *P*=0.29; I^2^=43%, *P*=0.09) (Table [3](#jah31353-tbl-0003){ref-type="table-wrap"}).

Sensitivity analysis revealed that MLHFQ outcome was stable when studies were removed 1 by 1. The significance of SF‐36 outcome was changed in the sensitivity analysis when 1 study was removed;[31](#jah31353-bib-0031){ref-type="ref"} this result offered inferior evidence for the effect of TCE on SF‐36. The sensitivity analysis did not affect heterogeneity of SF‐36 outcome, but sensitivity analysis affected heterogeneity of MLHFQ outcome.

Effects of TCE on Depression {#jah31353-sec-0032}
----------------------------

### Hamilton Depression Rating Scale {#jah31353-sec-0033}

Two articles[36](#jah31353-bib-0036){ref-type="ref"}, [47](#jah31353-bib-0047){ref-type="ref"} involving129 patients compared HAMD scores for patients performing TCEs and those in the control group. The HAMD scores of patients performing TCEs improved (MD −3.97, 95% CI −5.05 to −2.89, *P*\<0.001; I^2^=0, *P*=0.91) compared with those of patients in the control group, based on a random‐effects model (Figure [4](#jah31353-fig-0004){ref-type="fig"}C and Table [3](#jah31353-tbl-0003){ref-type="table-wrap"}).

### POMS Depression Scale {#jah31353-sec-0034}

Two articles[52](#jah31353-bib-0052){ref-type="ref"}, [53](#jah31353-bib-0053){ref-type="ref"} involving 116 patients were included to assess the effect of TCE on the POMS depression scale. The POMS depression scale scores of the patients performing TCEs significantly improved (MD −3.02, 95% CI −3.50 to −2.53, *P*\<0.001; I^2^=0%, *P*=0.76) compared with those of patients in the control group, based on a random‐effects model (Table [3](#jah31353-tbl-0003){ref-type="table-wrap"}).

Publication Bias {#jah31353-sec-0035}
----------------

The Egger\'s regression test results did not show any publication bias for SBP (asymmetry test *P*=0.46), DBP (asymmetry test *P*=0.192), heart rate (asymmetry test *P*=0.406), TG (asymmetry test *P*=0.503), TC (asymmetry test *P*=0.08), HDL‐C (asymmetry test *P*=0.814), 6‐minute walk test (asymmetry test *P*=0.871), and MLHFQ (asymmetry test *P*=0.304).

Discussion {#jah31353-sec-0036}
==========

TCEs are mind--body exercises that focus on posture, coordination of breathing patterns, and meditation. Several TCEs are used to treat patients with CVDs. Previous systematic reviews focused on specific TCEs, such as tai chi and qigong.[18](#jah31353-bib-0018){ref-type="ref"}, [56](#jah31353-bib-0056){ref-type="ref"}, [57](#jah31353-bib-0057){ref-type="ref"}, [58](#jah31353-bib-0058){ref-type="ref"} This systematic review compiled evidence from a large number of trials assessing the effectiveness of TCEs to evaluate the overall effect of TCEs on patients with CVD compared with other exercises or of the absence of any intervention.

This systematic review and meta‐analysis included 35 RCTs involving 2249 patients with CVD to provide further evidence of the effect of TCEs on physiological outcomes, biochemical outcomes, quality of life, and depression in CVD patients. The SBP, DBP, TG, TC, LDL‐C, HDL‐C, BNP, 6‐minute walk test, MLHFQ, SF‐36 (general health and physical function), HAMD, and POMS depression scale of patients performing TCEs significantly improved compared with those of the patients in the control group. The benefits of TCEs for SBP, DBP, TG, TC, LDL‐C, HDL‐C, MLHFQ, and depression of CVD patients reached certain levels that could signify clinical importance. In particular, the effects TCE on blood pressure and blood lipids are clinically significant because blood pressure and LDL‐C are the primary targets for cardiovascular risk reduction.

A meta‐analysis[59](#jah31353-bib-0059){ref-type="ref"} showed that by reducing the SBP and DBP by 10 and 5 mm Hg, respectively, TCE could reduce the occurrences of stroke and coronary heart disease by 41% and 22%, respectively. Another systematic review revealed that the morbidity and mortality of CVDs could be reduced by up to 50% if blood cholesterol was reduced by ≈20%, SBP by 10 to 15 mm Hg, and DBP by 5 to 8 mm Hg.[60](#jah31353-bib-0060){ref-type="ref"} Based on current evidence from systematic reviews, TCE could improve the quality of life and reduce the depression of CVD patients; however, no significant differences were found between patients performing TCEs and those in the control group in terms of heart rate, peak oxygen uptake, timed up and go test, and 12‐item GHQ.

Although the intensity of TCE ranged from low to moderate, we found that TCE could improve physiological outcomes (eg, blood pressure), biochemical outcomes (eg, cholesterol and TG), quality of life (eg, MLHFQ), and depression of patients with CVDs. TCE has a complex mechanism for treating CVD. TCE is based on the theoretical principles of traditional Chinese medicine. The integrated exercise of mind and body, which includes stillness of mind, flow of breath, movement of body, and self‐correction of posture, activates the natural self‐regulatory (self‐healing) ability and evokes a balanced release of endogenous neurohormones and a wide array of natural health recoverymechanisms.[61](#jah31353-bib-0061){ref-type="ref"} Nevertheless, the contribution of TCEs in improving the health of patients with CVD requires further investigation.

The pooled estimate of effect for the outcome (Figure [2](#jah31353-fig-0002){ref-type="fig"}) has significant heterogeneity. There may be important clinical and methodological differences among studies that influence the differences between intervention and controls. Some differences existed in inclusion criteria and among the participants, who came from different countries and may have different understandings of TCE. Different types of TCE include not only include tai chi but also baduanjin, yijinjing, and other forms. Even tai chi has a lot of branches.

Strengths and Limitations {#jah31353-sec-0037}
-------------------------

This paper is the first systematic review and meta‐analysis to assess and compare the effects of TCE with other exercises or with no intervention regarding physiological outcomes (eg, blood pressure), biochemical outcomes (eg, cholesterol and TG), quality of life, and depression among patients with CVD. Unlike prior systematic reviews, more than a quarter of the included studies were published within the past 2 years.

This systematic review searched a wide variety of electronic databases for relevant articles. We searched primarily for articles in the Chinese electronic database because TCEs originated in China. Two reviewers independently selected the studies, extracted the data, and evaluated the quality of the studies to decrease bias and transcription errors. Consequently, the results of our systematic review are considered robust.

Our meta‐analysis had several limitations. First, although all included studies were RCTs, only a few (9 of 35) clearly indicated allocation concealment in their experimental procedures; therefore, selection bias or confounding may be present. Moreover, only 8 of the included studies blinded their assessors. Second, only 2 or 3 of the included studies assessed the effect of TCE on BNP, timed up and go test, GHQ‐12, SF‐36, HAMD, and POMS. More quality RCTs are needed to have confidence in the results in the future. Third, although 6 electronic databases were searched systematically for relevant articles by using a prespecified search strategy and because publication bias was assessed by Egger\'s regression test, we did not search for any unpublished trials. Consequently, the probability of publication bias may also exist in our study. Fourth, the follow‐up durations of most studies were no longer than 1 year; therefore, we did not perform the meta‐analysis to assess the long‐term effect of TCE for CVD patients. Although each included study was an RCT, most of these studies did not adhere to the generally accepted standards in reporting clinical trials (eg, the Consolidated Standards of Reporting Trials statement).[62](#jah31353-bib-0062){ref-type="ref"} The methodological standards of future studies must be improved in terms of allocation concealment, blinding of outcome assessment, adequate follow‐up, and intention‐to‐treat analysis. Fifth, TCE includes different types of exercise, and it is necessary to have detailed subgroups for different types of TCE and different types of controls in the future.

Conclusions {#jah31353-sec-0038}
===========

This study showed that TCE could provide more benefits than other exercises or no intervention for decreasing SBP and DBP and improving biochemical outcomes, physical function, quality of life, and depression in patients with CVD. The results may improve some CVD risk factors; therefore, the clinical implications of our systematic review results showed that TCE should be useful for patients with CVD, medical staff, and health care decision makers. Nevertheless, extreme heterogeneity in the analyses remained unexplained, and the number of high‐quality studies was not large in the systematic review. More multicenter RCTs with large sample sizes must be conducted to assess the effects of TCEs in CVD patients. The long‐term effectiveness of TCEs for patients with CVD must also be evaluated. Theories about how TCE could treat patients with CVDs and prevent such diseases should be further clarified.
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